As another approach, a tumor microenvironment-activated RIBOTAC (TaRiboTAC) was developed to spatially confine RNase L recruitment to the acidic, oxidative conditions characteristic of the tumor microenvironment [41]. The gene discussed is RNASEL; the disease is neoplasm.